Prognostic impact of homologous recombination deficiency in advanced breast cancer treated with trastuzumab deruxtecan.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Junghoon Shin, Ryul Kim, Ji-Yeon Kim, Hee Kyung Ahn, Jin-Seok Ahn, Young Seok Ju, Yeon Hee Park
Institutions: Samsung Medical Center, Sungkyunkwan University
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410819710